
ControlPoint: Rapid, comprehensive animal diagnostics for improved pet health and wellness.
ControlPoint, an animal diagnostics company, was founded with the mission to enhance pet health and wellness through rapid and comprehensive diagnostic testing. The company focuses on providing veterinarians with quick and accurate results, allowing for timely and specific treatment of various conditions. ControlPoint's services include testing for multiple pathogens, particularly those causing upper respiratory infections in dogs, thereby extending the quality and duration of pets' lives.
Notable figures associated with ControlPoint include experts in veterinary medicine and biotechnology, although specific names are not disclosed. The company has made significant strides in the field of animal health diagnostics, notably by developing antibodies against bacteria and viruses responsible for common canine respiratory infections. This innovation has positioned ControlPoint as a key player in the veterinary diagnostics market, positively impacting pet care and veterinary practices.

MySimplePetLab
mysimplepetlab.com

AnimalBiome
animalbiome.com

Advanced Animal Diagnostics

Hypercell Technologies
hypercelltech.com

Embark Veterinary
embarkvet.com

ClueJay
cluejay.com

Nuclease Probe Technologies

Idexx
idexx.com

Paratus Diagnostics

PepiPets
pepipets.com

BioAmp diagnostics
bioampdx.com

Agricultural Solutions
Petsdx Veterinary Imaging
petsdx.com

Vetigenics
vetigenics.com

Moichor
moichor.com

Test Diagnostics
Cobio Diagnostics
cobio.co

DxDiscovery
dxdiscovery.com

Prompt Diagnostics
prompt-dx.com

ENTvantage Dx
entvantagedx.com
Companies similar to ControlPoint include MySimplePetLab, AnimalBiome, Advanced Animal Diagnostics and Hypercell Technologies.
ControlPoint was founded in 2020.
ControlPoint's headquarters is located in Campbell, CA, US.
ControlPoint's most recent funding round was for $256k (USD) in May 2022.
As of May 23, 2022, ControlPoint has disclosed funding of $256k (USD).
ControlPoint has 30 employees as of Feb 4, 2024.